These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 1340539)
1. Glucantime resistant Leishmania promastigotes are sensitive to pentostam. Moreira ES; Guerra JB; Petrillo-Peixoto Mde L Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539 [TBL] [Abstract][Full Text] [Related]
2. Glucantime susceptibility of Leishmania promastigotes under variable growth conditions. Moreira ES; Soares RM; Petrillo-Peixoto Mde L Parasitol Res; 1995; 81(4):291-5. PubMed ID: 7624285 [TBL] [Abstract][Full Text] [Related]
3. Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility. Moreira ES; Anacleto C; Petrillo-Peixoto ML Parasitol Res; 1998 Sep; 84(9):720-6. PubMed ID: 9766900 [TBL] [Abstract][Full Text] [Related]
4. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Grogl M; Thomason TN; Franke ED Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070 [TBL] [Abstract][Full Text] [Related]
5. Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines. Ferreira-Pinto KC; Miranda-Vilela AL; Anacleto C; Fernandes AP; Abdo MC; Petrillo-Peixoto ML; Moreira ES Can J Microbiol; 1996 Sep; 42(9):944-9. PubMed ID: 8864217 [TBL] [Abstract][Full Text] [Related]
6. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure. Grögl M; Oduola AM; Cordero LD; Kyle DE Exp Parasitol; 1989 Jul; 69(1):78-90. PubMed ID: 2543590 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes. Lucumi A; Robledo S; Gama V; Saravia NG Antimicrob Agents Chemother; 1998 Aug; 42(8):1990-5. PubMed ID: 9687395 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotes. Moreira ES; Petrillo-Peixoto ML Braz J Med Biol Res; 1991; 24(5):459-69. PubMed ID: 1823261 [TBL] [Abstract][Full Text] [Related]
9. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis. Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application]. Henao HH; Osorio Y; Saravia NG; Gómez A; Travi B Biomedica; 2004 Dec; 24(4):393-402. PubMed ID: 15678803 [TBL] [Abstract][Full Text] [Related]
12. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518 [TBL] [Abstract][Full Text] [Related]
13. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1. Mandal G; Mandal S; Sharma M; Charret KS; Papadopoulou B; Bhattacharjee H; Mukhopadhyay R PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003500. PubMed ID: 25714343 [TBL] [Abstract][Full Text] [Related]
14. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study. Özbilgin A; Çavuş İ; Yıldırım A; Kaya T; Ertabaklar H Turkiye Parazitol Derg; 2018 Mar; 42(1):11-19. PubMed ID: 29780014 [TBL] [Abstract][Full Text] [Related]
16. Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines. Gazola KC; Ferreira AV; Anacleto C; Michalick MS; Andrade AF; Moreira ES Parasitol Res; 2001 Nov; 87(11):935-40. PubMed ID: 11728019 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment. Robledo SM; Valencia AZ; Saravia NG J Parasitol; 1999 Apr; 85(2):360-6. PubMed ID: 10219320 [TBL] [Abstract][Full Text] [Related]
18. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy. Jackson JE; Tally JD; Ellis WY; Mebrahtu YB; Lawyer PG; Were JB; Reed SG; Panisko DM; Limmer BL Am J Trop Med Hyg; 1990 Nov; 43(5):464-80. PubMed ID: 2173431 [TBL] [Abstract][Full Text] [Related]
19. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes. Ephros M; Waldman E; Zilberstein D Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870 [TBL] [Abstract][Full Text] [Related]
20. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis. Martinez S; Looker DL; Berens RL; Marr JJ Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]